000 01511 a2200421 4500
005 20250517044338.0
264 0 _c20160915
008 201609s 0 0 eng d
022 _a1476-5594
024 7 _a10.1038/onc.2015.271
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPhatak, P
245 0 0 _aOverexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
_h[electronic resource]
260 _bOncogene
_cApr 2016
300 _a2087-97 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCELF1 Protein
_xphysiology
650 0 4 _aCarcinoma, Squamous Cell
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aCisplatin
_xpharmacology
650 0 4 _aEsophageal Neoplasms
_xgenetics
650 0 4 _aHumans
650 0 4 _aInhibitor of Apoptosis Proteins
_xphysiology
650 0 4 _aMicroRNAs
_xgenetics
650 0 4 _aSurvivin
700 1 _aByrnes, K A
700 1 _aMansour, D
700 1 _aLiu, L
700 1 _aCao, S
700 1 _aLi, R
700 1 _aRao, J N
700 1 _aTurner, D J
700 1 _aWang, J-Y
700 1 _aDonahue, J M
773 0 _tOncogene
_gvol. 35
_gno. 16
_gp. 2087-97
856 4 0 _uhttps://doi.org/10.1038/onc.2015.271
_zAvailable from publisher's website
999 _c25131858
_d25131858